MAPT and Parkinson disease: Higher CSF levels of FABP, ICAM-1, MMP3, SCF, and TF were associated with higher CSF levels of neurodegenerative/PD-specific biomarkers, namely t-Tau, p181-Tau, and α-synuclein in males and in females.